Fachliteratur Gastroenterologie: Neoplasien Oesophagus

Fr | De

Feedback | Impressum | Sitemap

Keine Artikel ausgewählt!

Warenkorb

Sie sind hier: Fachliteratursuche » Oesophagus » Neoplasie

24. Oktober 2026

Abklärungen / Diagnostik

Therapien

Guidelines

Fortbildung

News / Journalscreening

Schrift:

Seite 1 von 1997


	Artikel 1 - 20 / 39931

	Active surveillance versus standard surgery after neoadjuvant chemoradiotherapy for oesophageal cancer: long-term results of a cluster-randomised controlled trial (SANO). Ann Oncol Panday SSGG, van der Wilk BJ, Lagarde SM, Eyck BM, Rosman C, Noordman BJ, Valkema MJ, Bisseling TM, Coene PPLO, van Det MJ, Dekker JWT, van Dieren JM, Doukas M, van Esser S, Fiets WE, Hartgrink HH, Heisterkamp J, Holster IL, Klarenbeek B, Kouw E, Kouwenhoven EA, Luyer MD, Mostert B, Nieuwenhuijzen GAP, Oostenbrug LE, Pierie JP, van Sandick JW, Sosef MN, Spaander MCW, Valkema R, van der Zaag ES, Steyerberg EW, van Klaveren D, Wijnhoven BPL, van Lanschot JJB, SANO Study Group. PMID: 42918421 [PubMed - as supplied by publisher]
	Circulating MicroRNAs Reflect Systemic Inflammation and Metabolic Dysfunction in Oesophageal Squamous Cell Carcinoma-Associated Cachexia. J Cachexia Sarcopenia Muscle Li Y, Chen R, Lv X, Wei S, Xu Y, Ding S. PMID: 42910566 [PubMed - indexed for MEDLINE]
	Lymph Node Regression Improves Prognostic Stratification in Esophageal Squamous Cell Carcinoma Receiving Neoadjuvant Chemoimmunotherapy: A Multicenter Retrospective Cohort Study. MedComm (2020) Zheng J, Shen W, Cao J, Gao L, Zan L, Zhang T, Gong L, Duan X, Wang X, Wu Y, Tang P, Jiang H, Pang Q, Zhao G, Zhang W, Yan C. PMID: 42910074 [PubMed]
	Esophageal Carcinoma Incidence and Survival Analysis: A Population-Based Cancer Registry Study in Central India. Cureus Ghongade PV, Patil BU, Gupta A, Maliye S, Gangane N. PMID: 42909884 [PubMed]
	Visualizing the distribution of durvalumab targeting PD-L1 using quantitative fluorescence imaging in patients with esophageal cancer. Theranostics van der Waaij AM, van Ginkel YJ, Volkmer P, Kats-Ugurlu G, Huizinga HK, Hone Lopez S, de Haan JJ, Bijlsma R, van der Waaij LA, Muijs CT, Niezink AGH, van Etten B, Westerhof J, di Pietro M, Robinson DJ, Lub-de Hooge MN, Nagengast WB. PMID: 42909237 [PubMed - indexed for MEDLINE]
	Survival outcomes and safety of adding high-dose-rate intraluminal brachytherapy (HDR-ILBT) utilizing the novel balloon applicator (BRAXX) following concurrent chemoradiotherapy (CCRT) for non-surgical esophageal cancer: a prospective pilot and real-world comparative study. Am J Cancer Res Chen SH, Kao WH, Tsan DL, Yap WK, Hung TM, Chen MF, Pai PC, Lin AC, Lu WH, Tseng CK. PMID: 42908863 [PubMed]
	Efficacy of tislelizumab combined with nab-paclitaxel and nedaplatin in advanced esophageal squamous cell carcinoma and its impact on serum tumor markers. Am J Cancer Res Huang R, Shen G, Zhang W, Lin Y, Huang Z, Dai Y, Lin Y, Zhang Y. PMID: 42908730 [PubMed]
	Underweight Versus Obesity and Gastrointestinal Cancer Mortality in Type 2 Diabetes: A Nationwide Cohort Study. J Cachexia Sarcopenia Muscle Park JH, Han K, Choe HJ, Park SE, Lee WY, Moon SJ, Rhee EJ. PMID: 42908126 [PubMed - indexed for MEDLINE]
	Misreporting of study design and validation status in a study of early tumour shrinkage in esophageal squamous cell carcinoma. Cancer Imaging Khodamoradi E. PMID: 42907938 [PubMed - indexed for MEDLINE]
	Acetic acid chromoendoscopy for detection of neoplastic Barrett's oesophagus: stepped wedge cluster randomised controlled trial (ACID-trial). BMJ Beaufort IN, Boer LS, Milne AN, Alderlieste YA, Baars JE, Bos PR, Burger JPW, van Heel NCM, Ledeboer M, Lieverse RJ, van de Meeberg PC, Meeuse JJ, Naber AHJ, Pullens HJM, Scheffer RCH, Sikkema M, Stolk MFJ, Verbeek RE, Verhagen MAMT, van de Vrie W, Willems M, van Werkhoven CH, Weusten BLAM. PMID: 42907095 [PubMed - indexed for MEDLINE]
	A dual-prompt framework combining spatial-mask priors and clinical-text conditioning for CT-only GTV delineation in esophageal cancer: A multicenter study. Med Phys Sun H, Chen C, Chen J, Wang Q, Li J, An Z, Liu Y, Meng F, Jia L, Shi Z, Cui Y, Liu Y, Gong J, Huang D, Zhao L. PMID: 42905882 [PubMed - indexed for MEDLINE]
	Molecular mechanisms and therapeutic strategies of immunotherapy resistance in esophageal cancer. Front Immunol Pang Y, Jiang P, Liu K, Suo X, Zhang D, Xu Y, Ge Y, Fu Q, Gao S. PMID: 42903418 [PubMed - indexed for MEDLINE]
	Can Current Innovations in Diagnostic and Therapeutic Strategies Transform Gastroesophageal Cancer Care? Middle East J Dig Dis Alshwayyat S, Almasri N, Maraqa K, Abu Samrah S, Aljawabrah S, Abuhalaweh N, Alshwaiyat Y, Al-Shami R, Al-Zoubi L, Alswaiti Y, Altaweel H, Abid R, Alqasem K, Al-Kurdi MA. PMID: 42903379 [PubMed]
	Immune-related adverse events are associated with favorable clinical outcomes in esophageal cancer treated with immune checkpoint inhibitors: a systematic review and meta-analysis. Front Oncol Fan J, Chen D, Jia L. PMID: 42903106 [PubMed]
	Study protocol of a prospective, non-interventional cohort study evaluating the benefits of transjugular intrahepatic portosystemic shunt in patients with hepatocellular carcinoma receiving first-line atezolizumab plus bevacizumab (NISTIPS TRITICC-4, IKF092). Future Oncol Angendohr C, Weigel C, Kunstein A, Joerdens M, Goetze T, Al-Batran SE, Zäpf B, Gonzalez-Carmona M, Sahin C, Berres ML, Foerster F, Ben Khaled N, Koch C, Kandulski A, Wege H, Trebicka J, Jochheim LS, Dill MT, Springfeld C, Daum S, Treese C, Ehmer U, Luedde T, Bode J, Roderburg C. PMID: 42902603 [PubMed - as supplied by publisher]
	Eosinophilic Oesophagitis and Incidence of Gastrointestinal Cancer: A Population-Based Cohort Study. Aliment Pharmacol Ther Kurt G, Farkas DK, Dellon ES, Jensen ET, Sørensen HT. PMID: 42902446 [PubMed - as supplied by publisher]
	Effectiveness of personalized positioning management in preventing hypoxemia during sedated endoscopy: a retrospective study. BMC Gastroenterol Chen Y, Zhu J. PMID: 42902208 [PubMed - indexed for MEDLINE]
	Combined TIPS and TACE for patients with hepatocellular carcinoma and variceal bleeding secondary to portal vein tumor thrombus. BMC Gastroenterol Feng Z, Wu B, Xu Z, Yang W, Zhou H, Shi H, Liu S, Zhou W. PMID: 42902152 [PubMed - indexed for MEDLINE]
	Ociperlimab and tislelizumab in advanced esophageal squamous cell carcinoma (AdvanTIG-203): a phase II study. Nat Commun Wang F, Lin CY, Sun JM, Lu CH, Zhu X, Chen Z, Zhao Q, Kim IH, Pan Y, Zhang J, Chen Z, Tougeron D, Kim SB, Van Cutsem E, Zaanan A, Rivera F, Dechaphunkul A, Zuo Y, Wan Q, Zhang J, Zhou J, Xu RH. PMID: 42901884 [PubMed - indexed for MEDLINE]
	Management of cT2N0M0 esophageal cancer: a systematic review and meta-analysis. Dis Esophagus Eliya Y, Leng S, Litle VR, Asghari M, Kohn GP. PMID: 42900766 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 39931

Seite 1 von 1997



		Zeitfenster

Ironmedline

Das Fachportal für Eisenmangel >>

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung